Literature DB >> 7907244

Diagnosis and management of heart failure.

H J Dargie1, J J McMurray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7907244      PMCID: PMC2539274          DOI: 10.1136/bmj.308.6924.321

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  29 in total

1.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

2.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.

Authors:  K Chadda; S Goldstein; R Byington; J D Curb
Journal:  Circulation       Date:  1986-03       Impact factor: 29.690

3.  Epidemiologic aspects of heart failure.

Authors:  G C Sutton
Journal:  Am Heart J       Date:  1990-12       Impact factor: 4.749

4.  Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.

Authors:  B F Uretsky; M Jessup; M A Konstam; G W Dec; C V Leier; J Benotti; S Murali; H C Herrmann; J A Sandberg
Journal:  Circulation       Date:  1990-09       Impact factor: 29.690

5.  Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

Authors:  J N Cohn; D G Archibald; S Ziesche; J A Franciosa; W E Harston; F E Tristani; W B Dunkman; W Jacobs; G S Francis; K H Flohr
Journal:  N Engl J Med       Date:  1986-06-12       Impact factor: 91.245

6.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

7.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Authors:  M Packer; J R Carver; R J Rodeheffer; R J Ivanhoe; R DiBianco; S M Zeldis; G H Hendrix; W J Bommer; U Elkayam; M L Kukin
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

Review 8.  Dopamine and dopamine receptor agonists in cardiovascular therapy.

Authors:  M B Murphy; W J Elliott
Journal:  Crit Care Med       Date:  1990-01       Impact factor: 7.598

9.  Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure.

Authors:  J G Cleland; E Henderson; J McLenachan; I N Findlay; H J Dargie
Journal:  J Am Coll Cardiol       Date:  1991-03-01       Impact factor: 24.094

10.  Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.

Authors:  G A Riegger
Journal:  Eur Heart J       Date:  1991-06       Impact factor: 29.983

View more
  37 in total

Review 1.  Clinical case studies in heart failure management.

Authors:  R J MacFadyen; P Shiels; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 2.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

3.  The diagnosis of heart failure.

Authors:  A D Struthers
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

4.  Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study.

Authors:  Ahmet Fuat; A Pali S Hungin; Jeremy James Murphy
Journal:  BMJ       Date:  2003-01-25

Review 5.  Unmet need for diagnosis of heart failure: the view from primary care.

Authors:  F D R Hobbs
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

6.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 7.  Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis.

Authors:  Clare Davenport; Elaine Yee Lan Cheng; Yip Tung Tony Kwok; Annie Hiu On Lai; Taka Wakabayashi; Chris Hyde; Martin Connock
Journal:  Br J Gen Pract       Date:  2006-01       Impact factor: 5.386

8.  Dying from heart failure: lessons from palliative care. Many patients would benefit from palliative care at the end of their lives.

Authors:  L M Gibbs; J Addington-Hall; J S Gibbs
Journal:  BMJ       Date:  1998-10-10

9.  Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.

Authors:  S J McClure; L Caruana; A P Davie; S Goldthorp; J J McMurray
Journal:  BMJ       Date:  1998-08-22

10.  Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations.

Authors:  F D R Hobbs; R C Davis; A K Roalfe; R Hare; M K Davies
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.